Skip to main content

Table 3 Main results of the pooled data in the meta-analysis

From: CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects

 

No. (cases/controls)

C allele vs T allele

CC vs TT

(CC + TC) vs TT

  

OR (95%CI)

P (OR)

P (Q-test)

OR (95%CI)

P (OR)

P (Q-test)

OR (95%CI)

P (OR)

P (Q-test)

Total

1330/3688

1.13 (0.87-.1.48)

0.349

0.000

1.72 (0.99-3.01)

0.055

0.026

1.16 (0.86-1.55)

0.326

0.002

Ethnicity

        

Caucasian

521/1359

0.90 (0.59-.1.37)

0.629

0.062

2.02 (0.76-5.36)

0.160

0.462

0.85 (0.57-1.26)

0.415

0.127

Asian

623/1946

1.35 (0.90-2.02)

0.150

0.004

1.77 (0.72-4.35)

0.214

0.002

1.33 (1.09-1.62)

0.004

0.382

Mixed

186/383

1.11 (0.48-2.55)

0.807

0.029

1.40 (0.28-6.90)

0.681

0.227

1.24 (0.48-3.22)

0.654

0.021

Age groups

        

Adult AML

1183/2890

1.21 (0.88-1.66)

0.244

0.000

1.76 (0.94-3.30)

0.078

0.015

1.26 (0.88-1.81)

0.213

0.000

Childhood AML

147/938

1.02 (0.69-1.49)

0.938

0.620

1.78 (0.60-5.32)

0.299

0.376

0.97 (0.63-1.49)

0.877

0.856

  1. AML, acute myeloid leukemia.